Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gliceida Galarza Fortuna

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
JAMA Oncology|June 22, 2023
Developing an Ideal Risk Stratification Model for Metastatic Renal Cell CarcinomaGeorges Gebrael, Gliceida Galarza Fortuna, Neeraj Agarwal
British Journal of Haematology|April 2, 2024
Sequence not salvageDouglas W Sborov, Gliceida Galarza Fortuna, Patrick J Hayden
Trends in Cancer|July 13, 2023
Advances in the treatment of metastatic prostate cancerGeorges Gebrael, Gliceida Galarza Fortuna, Nicolas Sayegh, et al.
Critical Reviews in Oncology/Hematology|December 21, 2023
Predictors of response to neoadjuvant therapy in urothelial cancerNishita Tripathi, Gliceida Galarza Fortuna, Georges Gebrael, et al.
The Oncologist|September 20, 2025
The past, present, and future of myeloma staging and risk prognosticationMehmet Baysal, Kelley Julian, Douglas Sborov, et al.
Case Reports in Hematology|April 25, 2020
Reactivation of Epstein-Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab TreatmentAnthony J Febres-Aldana, Christopher A Febres-Aldana, Kathrin Dvir, et al.
Journal of Kidney Cancer and VHL|August 5, 2024
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic EventsGliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, et al.
Blood Cancer Journal|January 25, 2024
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic reviewKarun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, et al.
Therapeutic Advances in Urology|November 11, 2024
Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolixPatrick Campbell, Georges Gebrael, Arshit Narang, et al.
JAMA Network Open|July 18, 2024
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial CancersChadi Hage Chehade, Yeonjung Jo, Georges Gebrael, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
JAMA Oncology|June 22, 2023
Developing an Ideal Risk Stratification Model for Metastatic Renal Cell CarcinomaGeorges Gebrael, Gliceida Galarza Fortuna, Neeraj Agarwal
British Journal of Haematology|April 2, 2024
Sequence not salvageDouglas W Sborov, Gliceida Galarza Fortuna, Patrick J Hayden
Trends in Cancer|July 13, 2023
Advances in the treatment of metastatic prostate cancerGeorges Gebrael, Gliceida Galarza Fortuna, Nicolas Sayegh, et al.
Critical Reviews in Oncology/Hematology|December 21, 2023
Predictors of response to neoadjuvant therapy in urothelial cancerNishita Tripathi, Gliceida Galarza Fortuna, Georges Gebrael, et al.
The Oncologist|September 20, 2025
The past, present, and future of myeloma staging and risk prognosticationMehmet Baysal, Kelley Julian, Douglas Sborov, et al.
Case Reports in Hematology|April 25, 2020
Reactivation of Epstein-Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab TreatmentAnthony J Febres-Aldana, Christopher A Febres-Aldana, Kathrin Dvir, et al.
Journal of Kidney Cancer and VHL|August 5, 2024
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic EventsGliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, et al.
Blood Cancer Journal|January 25, 2024
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic reviewKarun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, et al.
Therapeutic Advances in Urology|November 11, 2024
Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolixPatrick Campbell, Georges Gebrael, Arshit Narang, et al.
JAMA Network Open|July 18, 2024
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial CancersChadi Hage Chehade, Yeonjung Jo, Georges Gebrael, et al.
Pageof 2